Ohio Public Employees Retirement System (OPERS)’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-11,630
Closed -$157K 1941
2020
Q2
$157K Buy
11,630
+7,519
+183% +$84.4K ﹤0.01% 1410
2020
Q1
$33K Buy
4,111
+1,696
+70% +$14.9K ﹤0.01% 1712
2019
Q4
$23K Buy
+2,415
New +$26K ﹤0.01% 1844

Other funds holding SPRO

Ohio Public Employees Retirement System (OPERS)'s SPRO Position: Q3 2020 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Spero Therapeutics (SPRO) in Q3 2020, closing a stake of 11,630 shares — an estimated $157K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in SPRO in Q4 2019 and held it in 3 quarters. The position peaked at $157K in Q2 2020. 78 funds tracked by Wall St. Rank hold SPRO as of Q3 2020.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Spero Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 11,630 Spero Therapeutics shares in Q3 2020, an estimated $157K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Spero Therapeutics in Q4 2019 and held it in 3 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Spero Therapeutics position peaked at $157K in Q2 2020.
  • 78 funds tracked by Wall St. Rank held Spero Therapeutics as of Q3 2020.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q3 2020, filed 16 Nov 2020.